(1)
Sulaymonov S.A., Nuriddinov N.N., Ochilov I.A. DAPAGLIFLOZIN AS PART OF COMBINATION THERAPY IN COPD COMORBID WITH HEART FAILURE: EFFECTS ON PULMONARY, CARDIAC, RENAL AND ENDOTHELIAL FUNCTION. imjrd 2026, 13, 76-86.